The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Crossroads Neurovascular, Inc. announced FDA 510(k) clearance for the company’s Path balloon guide catheter (BGC) for neurov ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...

InspireMD, Inc. announced that the FDA has granted premarket approval (PMA) of the company’s CGuard Prime carotid stent syst ...

Anaconda Biomed, SL, announced that it has received CE Mark certification for its ANA5 advanced neurovascular access funnel ...

AngioDynamics, Inc. announced first patient enrollment in the RECOVER-AV clinical trial. The prospective, multicenter, multination ...

Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for us ...

Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigati ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...